L-isoleucine-supplemented Oral Rehydration Solution in the Treatment of Acute Diarrhoea in Children: A Randomized Controlled Trial

Authors

  • NH Alam ICDDR,B, Dkaha
  • R Raqib ICDDR,B, Dkaha
  • H Ashraf ICDDR,B, Dkaha
  • F Qadri ICDDR,B, Dkaha
  • S Ahmed ICDDR,B, Dkaha
  • M Zasloff Department of Research and Translational Science, Georgetown University, Washington
  • B Agerberth Karolinska Institute, Stockholm
  • MA Salam ICDDR,B, Dhaka
  • N Gyr University Hospital, Basel
  • R Meier University Hospital, Liestal

DOI:

https://doi.org/10.3329/jhpn.v29i3.7864

Keywords:

Dehydration, Diarrhoea, Acute, Infantile, Double-blind method, Oral rehydration solutions, Randomized controlled trials, Bangladesh

Abstract

Antimicrobial peptides represent an important component of the innate immune defenses of living organisms, including humans. They are broad-spectrum surface-acting agents secreted by the epithelial cells of the body in response to infection. Recently, L-isoleucine and its analogues have been found to induce antimicrobial peptides. The objectives of the study were to examine if addition of L-isoleucine to oral rehydration salts (ORS) solution would reduce stool output and/or duration of acute diarrhoea in children and induce antimicrobial peptides in intestine. This double-blind randomized controlled trial was conducted at the Dhaka Hospital of ICDDR,B. Fifty male children, aged 6-36 months, with acute diarrhoea and some dehydration, attending the hospital, were included in the study. Twenty-five children received L-isoleucine (2 g/L)-added ORS (study), and 25 received ORS without L-isoleucine (control). Stool weight, ORS intake, and duration of diarrhoea were the primary outcomes. There was a trend in reduction in mean±standard deviation (SD) daily stool output (g) of children in the L-isoleucine group from day 2 but it was significant on day 3 (388±261 vs 653±446; the difference between mean [95% confidence interval (CI) (-)265 (-509, -20); p=0.035]. Although the cumulative stool output from day 1 to day 3 reduced by 26% in the isoleucine group, it was not significant. Also, there was a trend in reduction in the mean±SD intake of ORS solution (mL) in the L-isoleucine group but it was significant only on day 1 (410±169 vs 564±301), the difference between mean (95% CI) (-)154 (-288, -18); p=0.04. The duration (hours) of diarrhoea was similar in both the groups. A gradual increase in stool concentrations of ß-defensin 2 and 3 was noted but they were not significantly different between the groups. L-isoleucine-supplemented ORS might be beneficial in reducing stool output and ORS intake in children with acute watery diarrhoea. A further study is warranted to substantiate the therapeutic effect of L-isoleucine.

Key words: Dehydration; Diarrhoea, Acute; Diarrhoea, Infantile; Double-blind method; Oral rehydration solutions; Randomized controlled trials; Bangladesh

DOI: http://dx.doi.org/10.3329/jhpn.v29i3.7864

J HEALTH POPUL NUTR 2011 Jun;29(3):183-190

Downloads

Download data is not yet available.
Abstract
701
PDF
749

Downloads

How to Cite

Alam, N., Raqib, R., Ashraf, H., Qadri, F., Ahmed, S., Zasloff, M., Agerberth, B., Salam, M., Gyr, N., & Meier, R. (2011). L-isoleucine-supplemented Oral Rehydration Solution in the Treatment of Acute Diarrhoea in Children: A Randomized Controlled Trial. Journal of Health, Population and Nutrition, 29(3), 183–190. https://doi.org/10.3329/jhpn.v29i3.7864

Issue

Section

Original Papers